COVID-19 Infection-Preventing Clinical Deterioration

Christopher W Seymour^{1

2}, Howard Bauchner³, Robert M Golub⁴

Affiliations

¹ Associate Editor, JAMA.
² Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
³ Editor, JAMA.
⁴ Deputy Editor, JAMA.

Comment

Christopher W Seymour et al. JAMA. 2020.

. 2020 Dec 8;324(22):2300.

doi: 10.1001/jama.2020.21720.

Christopher W Seymour^{1

2}, Howard Bauchner³, Robert M Golub⁴

¹ Associate Editor, JAMA.
² Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
³ Editor, JAMA.
⁴ Deputy Editor, JAMA.

No abstract available

Comment on

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial.
Lenze EJ, Mattar C, Zorumski CF, Stevens A, Schweiger J, Nicol GE, Miller JP, Yang L, Yingling M, Avidan MS, Reiersen AM. Lenze EJ, et al. JAMA. 2020 Dec 8;324(22):2292-2300. doi: 10.1001/jama.2020.22760. JAMA. 2020. PMID: 33180097 Free PMC article. Clinical Trial.